Industry anticipates policy reversal for embryonic stem cells

11/10/2008 | Washington Post, The

Scientists and companies working on treatments based on stem cells are looking forward to President-elect Barack Obama's plan to repeal a directive restricting the use of federal funds for embryonic stem cell research. The move could boost interest and investment in firms such as Advanced Cell Technology, which has been struggling to obtain financing for research.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA